Literature DB >> 27521344

New Murine Model of Early Onset Autoimmune Thyroid Disease/Hypothyroidism and Autoimmune Exocrinopathy of the Salivary Gland.

Timothy Daniel Kayes1, Gary A Weisman2, Jean M Camden2, Lucas T Woods2, Cole Bredehoeft1, Edward F Downey1, James Cole1, Helen Braley-Mullen3.   

Abstract

Sixty to seventy percent of IFN-γ(-/-) NOD.H-2h4 mice given sodium iodide (NaI)-supplemented water develop a slow onset autoimmune thyroid disease, characterized by thyrocyte epithelial cell (TEC) hyperplasia and proliferation (H/P). TEC H/P develops much earlier in CD28(-/-) mice and nearly 100% (both sexes) have severe TEC H/P at 4 mo of age. Without NaI supplementation, 50% of 5- to 6-mo-old CD28(-/-)IFN-γ(-/-) mice develop severe TEC H/P, and 2-3 wk of NaI is sufficient for optimal development of severe TEC H/P. Mice with severe TEC H/P are hypothyroid, and normalization of serum thyroxine levels does not reduce TEC H/P. Activated CD4(+) T cells are sufficient to transfer TEC H/P to SCID recipients. Thyroids of mice with TEC H/P have infiltrating T cells and expanded numbers of proliferating thyrocytes that highly express CD40. CD40 facilitates, but is not required for, development of severe TEC H/P, as CD40(-/-)IFN-γ(-/-)CD28(-/-) mice develop severe TEC H/P. Accelerated development of TEC H/P in IFN-γ(-/-)CD28(-/-) mice is a result of reduced regulatory T cell (Treg) numbers, as CD28(-/-) mice have significantly fewer Tregs, and transfer of CD28(+) Tregs inhibits TEC H/P. Essentially all female IFN-γ(-/-)CD28(-/-) NOD.H-2h4 mice have substantial lymphocytic infiltration of salivary glands and reduced salivary flow by 6 mo of age, thereby providing an excellent new model of autoimmune exocrinopathy of the salivary gland. This is one of very few models where autoimmune thyroid disease and hypothyroidism develop in most mice by 4 mo of age. This model will be useful for studying the effects of hypothyroidism on multiple organ systems.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27521344      PMCID: PMC5010957          DOI: 10.4049/jimmunol.1600133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Interleukin (IL)-12-driven primary hypothyroidism: the contrasting roles of two Th1 cytokines (IL-12 and interferon-gamma).

Authors:  Hiroaki Kimura; Shey-Cherng Tzou; Roberto Rocchi; Miho Kimura; Koichi Suzuki; Albert F Parlow; Noel R Rose; Patrizio Caturegli
Journal:  Endocrinology       Date:  2005-04-28       Impact factor: 4.736

2.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

3.  High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice.

Authors:  N F Bernard; F Ertug; H Margolese
Journal:  Diabetes       Date:  1992-01       Impact factor: 9.461

Review 4.  Thyroid transcription factors in development, differentiation and disease.

Authors:  Lara P Fernández; Arístides López-Márquez; Pilar Santisteban
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

5.  A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Authors:  S Cha; J Brayer; J Gao; V Brown; S Killedar; U Yasunari; A B Peck
Journal:  Scand J Immunol       Date:  2004-12       Impact factor: 3.487

6.  Iodine and IFN-gamma synergistically enhance intercellular adhesion molecule 1 expression on NOD.H2h4 mouse thyrocytes.

Authors:  Rajni B Sharma; Judy D Alegria; Monica V Talor; Noel R Rose; Patrizio Caturegli; C Lynne Burek
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

7.  Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.

Authors:  Vincent G DeMarco; Javad Habibi; Guanghong Jia; Annayya R Aroor; Francisco I Ramirez-Perez; Luis A Martinez-Lemus; Shawn B Bender; Mona Garro; Melvin R Hayden; Zhe Sun; Gerald A Meininger; Camila Manrique; Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2015-05-26       Impact factor: 10.190

8.  Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.

Authors:  M Hebbar; P Jeannin; G Magistrelli; P-Y Hatron; E Hachulla; B Devulder; J-Y Bonnefoy; Y Delneste
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 10.  The story of CD4+ CD28- T cells revisited: solved or still ongoing?

Authors:  Kathrin Maly; Michael Schirmer
Journal:  J Immunol Res       Date:  2015-03-05       Impact factor: 4.818

View more
  8 in total

1.  P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.

Authors:  Mahmoud G Khalafalla; Lucas T Woods; Jean M Camden; Aslam A Khan; Kirsten H Limesand; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

Review 2.  Therapeutic potential for P2Y2 receptor antagonism.

Authors:  Kimberly J Jasmer; Kevin Muñoz Forti; Lucas T Woods; Seunghee Cha; Gary A Weisman
Journal:  Purinergic Signal       Date:  2022-10-11       Impact factor: 3.950

Review 3.  The NOD Mouse Beyond Autoimmune Diabetes.

Authors:  Anne-Marie Aubin; Félix Lombard-Vadnais; Roxanne Collin; Holly A Aliesky; Sandra M McLachlan; Sylvie Lesage
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

Review 4.  The Association of Sjögren Syndrome and Autoimmune Thyroid Disorders.

Authors:  Chiara Baldini; Francesco Ferro; Marta Mosca; Poupak Fallahi; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-03       Impact factor: 5.555

5.  Effect of Excess Iodide Intake on Salivary Glands in a Swiss Albino Mice Model.

Authors:  Gloria Romina Ross; Emanuel Fabersani; Matías Russo; Alba Gómez; Hugo Japaze; Silvia Nelina González; Paola Gauffin Cano
Journal:  Biomed Res Int       Date:  2017-11-08       Impact factor: 3.411

6.  Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren's Syndrome Salivary Glands.

Authors:  Erich Horeth; Akinsola Oyelakin; Eun-Ah Christine Song; Monika Che; Jonathan Bard; Sangwon Min; Jeremy Kiripolsky; Jill M Kramer; Satrajit Sinha; Rose-Anne Romano
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 8.786

7.  Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.

Authors:  Lili Li; Kimberly J Jasmer; Jean M Camden; Lucas T Woods; Adam L Martin; Yong Yang; Maria Layton; Michael J Petris; Olga J Baker; Gary A Weisman; Carisa K Petris
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

8.  P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

Authors:  Kimberly J Jasmer; Lucas T Woods; Kevin Muñoz Forti; Adam L Martin; Jean M Camden; Marco Colonna; Gary A Weisman
Journal:  Arch Oral Biol       Date:  2021-02-03       Impact factor: 2.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.